12:00 AM
May 27, 2013
 |  BC Week In Review  |  Company News  |  Deals

J&J, Royal DSM deal

DSM said that on April 13, 2012, Percivia LLC terminated the PER.C6 biosimilars product development business as part of a restructuring of the company. Percivia, formerly Percivia PER.C6 Development Center,...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >